Panadol ActiFast Soluble Tablets

Panadol is a globally recognized brand of paracetamol, first introduced to the market in the mid-1950s. The product shown, Panadol ActiFast Soluble Tablets, is a specific formulation designed for faster absorption and fast pain relief for conditions like headaches and fever.

Originally developed by Sterling Drug in the United Kingdom, the brand has undergone several changes in ownership through corporate mergers and divestitures. For several decades, it was a cornerstone of the GlaxoSmithKline (GSK) consumer healthcare portfolio. However, following a significant corporate spin-off in 2022, the brand is now managed and owned by Haleon, an independent company focused entirely on consumer health products.

Manufacturing for Panadol occurs in multiple locations around the world to serve different regional markets, including major facilities in Ireland, Australia, and various countries in Southeast Asia and the Middle East.